Cutia Therapeutics (HKG:2487)
Hong Kong · Delayed Price · Currency is HKD 2.690
+0.040 (1.51%)
Jul 9, 2026, 3:51 PM HKT
Cutia Therapeutics Market Cap
Cutia Therapeutics has a market cap or net worth of 977.46 million as of July 9, 2026. Its market cap has decreased by -73.90% in one year.
Market Cap
977.46M
Enterprise Value
453.50M
Revenue
374.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.69
Market Cap Chart
Since June 12, 2023, Cutia Therapeutics's market cap has decreased from 6.67B to 977.46M, a decrease of -85.35%. That is a compound annual growth rate of -46.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 977.46M | -40.75% |
| Dec 31, 2025 | 1.65B | -26.86% |
| Dec 31, 2024 | 2.26B | -32.43% |
| Dec 29, 2023 | 3.34B | -49.98% |
| Jun 12, 2023 | 6.67B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HighTide Therapeutics | 1.54B |
| Zhaoke Ophthalmology | 1.44B |
| Beijing Biostar Pharmaceuticals | 1.34B |
| CANbridge Pharmaceuticals | 1.17B |
| Cloudbreak Pharma | 1.01B |
| Kintor Pharmaceutical | 1.01B |
| Sunho Biologics | 970.43M |
| Brii Biosciences | 822.86M |